Common use of Termination Effect of Termination Clause in Contracts

Termination Effect of Termination. (a) Subject to the resolution of any disputes in accordance with Sections 7(l) and 21 hereof, in the event that the Approval With Label Milestone Date or the Approval Without Label Date shall not have occurred on or prior to the Approval Deadline, this Agreement shall terminate at 5:00 p.m., New York City time, on the Approval Deadline.

Appears in 3 contracts

Samples: Consideration Agreement (Endo Pharmaceuticals Holdings Inc), Contingent Cash Consideration Agreement (Endo Pharmaceuticals Holdings Inc), Contingent Cash Consideration Agreement (Indevus Pharmaceuticals Inc)

AutoNDA by SimpleDocs

Termination Effect of Termination. (a) Subject to the resolution of any disputes in accordance with Sections 7(l7(m) and 21 22 hereof, in the event that the Approval With Label Milestone Date or the Approval Without Label Date shall not have occurred on or prior to the Approval Deadline, this Agreement shall will terminate at 5:00 p.m., New York City time, on the Approval Deadlineearlier of (i) the date that all payments are sent by the Paying Agent in respect of the payment date set forth in any certificate delivered pursuant to Section 7(a)(i) and Section 7(b)(i) hereof and (ii) the Termination Date.

Appears in 3 contracts

Samples: Consideration Agreement (Teva Pharmaceutical Industries LTD), Contingent Cash Consideration Agreement (Nupathe Inc.), Contingent Cash Consideration Agreement (Nupathe Inc.)

AutoNDA by SimpleDocs

Termination Effect of Termination. (a) Subject to the resolution of any disputes in accordance with Sections 7(l7(k) and 21 hereof, in the event that the Approval With Label Milestone Date or the Approval Without Label Date shall not have occurred on or prior to the Approval Deadline, this Agreement shall terminate at 5:00 p.m., New York City time, on the Approval Deadline.

Appears in 3 contracts

Samples: Octreotide Contingent Cash Consideration Agreement (Endo Pharmaceuticals Holdings Inc), Octreotide (Endo Pharmaceuticals Holdings Inc), Octreotide Contingent Cash Consideration Agreement (Indevus Pharmaceuticals Inc)

Time is Money Join Law Insider Premium to draft better contracts faster.